Pharmacokinetics of Budesonide (Entocort ™ EC) Capsules for Crohn’s Disease

Author： Edsbäcker Staffan  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.43, Iss.12, 2004-01, pp. : 803-821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Budesonide (Entocort EC Capsules): A Review of its Therapeutic Use in the Management of Active Crohn's Disease in Adults

By McKeage K.   Goa K.L.  

Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. : 2263-2282

Adis International

Access to resources Recommend Favorite

Budesonide for Crohn's disease

By Seow Cynthia H   Benchimol Eric I   Steinhart A Hillary   Griffiths Anne M   Otley Anthony R  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 971-979

Informa Healthcare

Access to resources Recommend Favorite

Therapy of Crohn’s disease in childhood

By Beattie R Mark   Bremner A Ronald F  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 809-825

Informa Healthcare

Access to resources Recommend Favorite

Budesonide improves QOL in Crohn's disease

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 360, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness of Budesonide Controlled Ileal Release (CIR) Capsules as Maintenance Therapy versus No Maintenance Therapy for Ileocaecal Crohn's Disease in Sweden

By Noble I.  

Clinical Drug Investigation, Vol. 15, Iss. 2, 1998-02 ,pp. : 123-136

Adis International

Access to resources Recommend Favorite